Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
February 26, 2024
As policymakers and financiers set their priorities for 2024, we gathered a group of experts who've been working on pandemics and pandemic financing from a range of perspectives including epidemiology, economics, insurance, policy, and advocacy. The purpose of our event was to map out the next steps...
Blog Post
December 18, 2023
The Lancet Investing in Health Commission, led by Larry Summers and Dean Jamison in 2013, envisioned a grand convergence in key health indicators by 2035 between low-income and low-middle-income countries and the best-performing middle-income countries. Given significant global changes since the rep...
Blog Post
November 15, 2023
During the COVID-19 pandemic, whole genomic sequencing (WGS)-based surveillance played a key role in identifying variants of concern, investigating their spread and transmissibility, and facilitating the design and optimization of medical countermeasures, including diagnostic tools and vaccines. How...
Blog Post
October 30, 2023
Realizing the Sustainable Development Goals (SDGs) and tackling the climate crisis in developing nations demands substantial investments. A recent report commissioned by the G20 estimated that for developing countries (encompassing low-income, lower-middle-income, and upper-middle-income nations), a...
Blog Post
September 14, 2023
COVID-19 is fading from public discussion, countries’ , and hopes for a safer and fairer future are being dashed by potentially watered-down political commitments. Yet people around the world continue to feel the impacts of COVID-19 every day, other infectious disease threats have not magically gone...
Blog Post
September 05, 2023
Today the Africa Centers for Disease Control’s (ACDC) Health Economics Programme (HEP) has published a new policy brief on the cost-effectiveness of two COVID-19 oral antivirals (COAVs), a nirmatrelvir/ritonavir combination, developed by Pfizer and sold under the name Paxlovid, and Molnupiravir, dev...
Blog Post
August 30, 2023
Developing Asia as a region has experienced rapid growth over the past three decades. What have these episodes of sustained growth meant for income inequality? Has the region had “inclusive growth,” meaning growth which saw incomes rise without inequality increasing, or has inequality gotten worse? ...
Blog Post
August 02, 2023
The future of such spending in countries currently experiencing or at high risk of debt distress is particularly troubling. A country is in debt distress when its ability to service domestic and external debt is impaired. This blog post delves into these issues based on more recent health spending a...
Blog Post
July 25, 2023
As the RST builds momentum and scores of countries seek its concessional loans and technical assistance, a new CGD paper, The Resilience and Sustainability Trust: Early Learning and Challenges from Costa Rica and Rwanda, provide early learning from the point of view of lower-income countries themsel...